Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesReimbursement/Payment PolicyBlue Cross Blue Shield OK — I.E.I. Lab Coverage Up…
    Ask Trek AI about this page
    CurrentBlue Cross Blue Shield - OklahomaPolicy CPCPLAB023

    Diagnosis of Idiopathic Environmental Intolerance — Laboratory Testing and Reimbursement

    Customize your policy alerts

    Sign up for Blue Cross Blue Shield - Oklahoma Policy CPCPLAB023 alerts

    Get alerted when Policy CPCPLAB023 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy governs reimbursement for laboratory tests related to diagnosis and evaluation of idiopathic environmental intolerance; plan documents may further limit coverage and not all requirements apply to every product.

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Policy Summary
    PayerBlue Cross Blue Shield - Oklahoma
    PolicyDiagnosis of Idiopathic Environmental Intolerance — Laboratory Testing and Reimbursement
    Policy CodePolicy CPCPLAB023
    Change TypeRevisions to exclusions and wording clarifications
    Effective DateMay 1, 2026
    Last ReviewJan 12, 2026
    Next Review Date
    Key ActionSubmit accurate documentation and be prepared to provide additional information upon request; verify plan documents before ordering tests that may be non-reimbursable.
    SourceLink
    POLICY UPDATE CHANGES

    Reimbursement Information items #2 and #3 were reworded from 'In all circumstances' to 'For asymptomatic individuals and/or during general encounters without abnormal findings'.

    Items #4, #5, #6, and #8 in Reimbursement Information were edited for consistency.

    Breath hydrogen and/or breath methane testing was clarified to be not reimbursable under any circumstances (item #7).

    The Reimbursement Policy section was removed during the update.

    8explicit non-reimbursable test categories listed
    27+procedure codes listed (partial code list)
    01/12/2026most recent policy update/approval date
    05/01/2026plan effective date

    Coverage Criteria and Non-Reimbursable Tests

    Non-reimbursable tests and test categories

    Not reimbursable when the following conditions apply:

    Laboratory tests designed to confirm the diagnosis of idiopathic environmental illness are not reimbursable.
    For asymptomatic individuals and/or during general encounters without abnormal findings, screening of blood, saliva, serum, plasma, urine, and/or stool for volatile solvents, organic acids, and organophosphates is not reimbursable.
    For asymptomatic individuals and/or during general encounters without abnormal findings, profiling of phthalates and parabens using blood, serum, plasma, saliva, urine, and/or stool is not reimbursable.
    For asymptomatic individuals and/or during general encounters without abnormal findings, profiling of chlorinated pesticides, including DDE and DDT, using blood, serum, plasma, saliva, urine, and/or stool is not reimbursable.
    For asymptomatic individuals and/or during general encounters without abnormal findings, testing of blood, serum, plasma, saliva, urine, and/or stool samples for carnitine sufficiency, oxidative stress and antioxidant sufficiency, detoxification adequacy, methylation sufficiency status, lipoic acid and CoQ10 sufficiency, and/or intestinal hyperpermeability is not reimbursable.
    For asymptomatic individuals and/or during general encounters without abnormal findings, testing of blood, serum, plasma, saliva, urine, and/or stool samples for vitamin sufficiency, mineral sufficiency, and/or nutritional analysis is not reimbursable.
    Breath hydrogen and/or breath methane testing is not reimbursable (applies under any circumstances).
    For asymptomatic individuals and/or during general encounters without abnormal findings, testing of blood, serum, urine, cerebrospinal fluid, fingernails, hair, and/or stool samples for metals is not reimbursable.

    Procedure Codes and Coding Guidance

    Listed procedure codes (not exhaustive)CPT
    82108
    82127
    82136
    82139
    82300
    82379
    82380
    82441
    82495
    82507
    1–10 of 42
    1/5

    Provider Responsibilities and Reimbursement Restrictions

    Documentation Required

    Documentation and Claim Review Responsibilities

    Providers are responsible for submission of accurate documentation of services performed. Providers are expected to submit claims using valid code combinations from HIPAA-approved code sets and to follow industry-standard coding guidelines (e.g., UB, AMA CPT, HCPCS, ICD-10-CM/PCS, NDCs, DRG, CMS NCCI). Claims are subject to code edit protocols and may be reviewed against benefit terms, provider contract language, medical policies, clinical payment and coding policies, and coding software logic. Upon request, the provider must submit additional documentation to support medical necessity and coding. Failure to provide requested documentation may result in claim denial or recoupment.

    • Submit complete medical records and test reports when requested
    • Code claims per current CPT/HCPCS/ICD-10 guidance and payer-specific rules
    • Claims are subject to retrospective review and recovery if documentation does not support billed services
    Prior Authorization

    Reimbursement Restrictions and Prior Authorization Implications

    Key Definitions

    Diagnosis (policy scope)
    DiagnosisIdiopathic Environmental Intolerance (policy title diagnosis)
    Policy NumberCPCPLAB023
    Approval / Most recent updateJan. 12, 2026
    Plan Effective DateMay 1, 2026
    ScopeThis policy governs reimbursement for laboratory tests related to diagnosis and evaluation of idiopathic environmental intolerance; not all requirements apply to each product.
    Plan documents (definition & precedence)
    Governing documents
    Policy Summary
    PayerBlue Cross Blue Shield - Oklahoma
    PolicyDiagnosis of Idiopathic Environmental Intolerance — Laboratory Testing and Reimbursement
    Policy CodePolicy CPCPLAB023
    Change TypeRevisions to exclusions and wording clarifications
    Effective DateMay 1, 2026
    Last ReviewJan 12, 2026
    Next Review Date
    Key ActionSubmit accurate documentation and be prepared to provide additional information upon request; verify plan documents before ordering tests that may be non-reimbursable.
    SourceLink
    On This Page
    Coverage Criteria and Non-Reimbursable TestsProcedure Codes and Coding GuidanceProvider Responsibilities and Reimbursement RestrictionsKey Definitions

    Prior authorization and plan coverage determinations govern reimbursement. Providers should verify member benefits and any prior authorization requirements before ordering tests. Tests explicitly described as not reimbursable in this policy will be denied regardless of diagnosis when billed for asymptomatic individuals or general encounters without abnormal findings (see list).

    • Not reimbursable for asymptomatic individuals and/or general encounters without abnormal findings: volatile solvents, organic acids, organophosphates, phthalates, parabens, chlorinated pesticides (including DDE/DDT), carnitine/oxidative stress/detoxification/methylation/lipoic acid/CoQ10/intestinal hyperpermeability testing, vitamin/mineral/nutritional analysis, and testing for metals in blood/serum/plasma/saliva/urine/cerebrospinal fluid/fingernails/hair/stool
    • Breath hydrogen and/or breath methane testing is not reimbursable under any circumstances
    • Confirm prior authorization and benefit coverage in the member's plan documents; provider contract or plan document controls if conflicts arise
    Certificates of Health Care Benefits, benefit booklets, Summary Plan Descriptions, and other coverage documents
    Hierarchy in conflictIf a conflict arises between this Clinical Payment and Coding Policy and any plan document under which a member is entitled to Covered Services, the plan document will govern.
    Provider contract precedenceIf a conflict arises between this policy and any provider contract, the provider contract will govern for services provided under that contract.
    Plan discretionBlue Cross and Blue Shield of Oklahoma may use reasonable discretion interpreting and applying this policy; BCBSOK has final discretionary authority to the extent provided under plan documents.